Literature DB >> 9456210

What attitudes and beliefs underlie patients' decisions about participating in chemotherapy trials?

H J Sutherland1, R da Cunha, G A Lockwood, J E Till.   

Abstract

The theory of reasoned action, which postulates that personal attitudes and external social influences predict intentions to undertake a behavior, was used as a conceptual framework for developing a questionnaire to elicit beliefs and attitudes associated with the decision to participate in a hypothetical cancer chemotherapy trial. After completing the questionnaire, two-thirds of the 150 respondents indicated they would enroll in such a trial if it were available. Considerable variation existed in both "universal" and "trial-specific" beliefs and attitudes underpinning their intentions. A substantial amount of the variance in "intention" to participate was explained by "attitude" alone (75%). Social influences, although statistically significant, made a mere 1% additional contribution. One interpretation is that subjective expected-utility theory, which essentially predicts beliefs or "attitude," is a better model. The authors conclude that both theories may be criticized regarding how well they capture the rationality and nuances of decision behavior.

Entities:  

Mesh:

Year:  1998        PMID: 9456210     DOI: 10.1177/0272989X9801800113

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  8 in total

1.  Pilot study of a point-of-use decision support tool for cancer clinical trials eligibility.

Authors:  P P Breitfeld; M Weisburd; J M Overhage; G Sledge; W M Tierney
Journal:  J Am Med Inform Assoc       Date:  1999 Nov-Dec       Impact factor: 4.497

2.  The accuracy and efficiency of electronic screening for recruitment into a clinical trial on COPD.

Authors:  Christopher N Schmickl; Man Li; Guangxi Li; Marnie M Wetzstein; Vitaly Herasevich; Ognjen Gajic; Roberto P Benzo
Journal:  Respir Med       Date:  2011-05-14       Impact factor: 3.415

Review 3.  Recruiting underserved populations to dermatologic research: a systematic review.

Authors:  Chaya R Spears; Bridgit V Nolan; Jenna L O'Neill; Thomas A Arcury; Joseph G Grzywacz; Steven R Feldman
Journal:  Int J Dermatol       Date:  2011-04       Impact factor: 2.736

4.  Discussions of cancer clinical trials with the National Cancer Institute's Cancer Information Service.

Authors:  Margaret M Byrne; Julie Kornfeld; Robin Vanderpool; Marc Belanger
Journal:  J Health Commun       Date:  2011-12-12

5.  Typologies of Altruistic and Financial Motivations for Research Participation.

Authors:  Lisa J Chin; Jacqueline A Berenson; Robert L Klitzman
Journal:  J Empir Res Hum Res Ethics       Date:  2016-10       Impact factor: 1.742

6.  How important is the opinion of significant others to cancer patients' adjuvant chemotherapy decision-making?

Authors:  A M Stiggelbout; S J T Jansen; W Otten; M C M Baas-Thijssen; H van Slooten; C J H van de Velde
Journal:  Support Care Cancer       Date:  2006-11-21       Impact factor: 3.603

7.  Lung cancer patients' decisions about clinical trials and the theory of planned behavior.

Authors:  Gwendolyn P Quinn; Christie L Pratt; Kathy Bryant-George; Vicki D Caraway; Bonnie Paternoster; Tere Roldan; Andrea Shaffer; Cynthia O Shimizu; Elizabeth J Vaughn; Charles Williams; Gerold Bepler
Journal:  J Cancer Educ       Date:  2011-12       Impact factor: 2.037

8.  Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.

Authors:  S Manne; D Kashy; T Albrecht; Y-N Wong; A Lederman Flamm; A B Benson; S M Miller; Linda Fleisher; J Buzaglo; N Roach; M Katz; E Ross; M Collins; D Poole; S Raivitch; D M Miller; T G Kinzy; T Liu; N J Meropol
Journal:  Eur J Cancer Care (Engl)       Date:  2014-01-28       Impact factor: 2.520

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.